Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study

Objectives: Varied substance use outcomes have been reported among individuals with a hepatitis C viral (HCV) infection on opioid agonist treatment (OAT) for opioid use disorder. Accordingly, the current study sought to evaluate the association between HCV serostatus, among other factors, and opioid...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Paige Guyatt, Glenda Babe, Anastasia Gayowsky, Tea Rosic, Myanca Rodrigues, Paxton Bach, Richard Perez, Claire de Oliveira, Jeffrey H. Samet, Geneviève Kerkerian, Jessica Hann, Joanna C. Dionne, Aijaz Ahmed, Donghee Kim, Seonaid Nolan, Lehana Thabane, Zainab Samaan, Brittany B. Dennis
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2025-09-01
Цуврал:	Drug and Alcohol Dependence Reports
Нөхцлүүд:	Opioid use disorder (OUD) Hepatitis C virus (HCV) Opioid agonist therapy (OAT) Opioid related harms (ORH)
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2772724625000514
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!